Introgen Anticipates Completion Of Advexin Rolling BLA Submission In 2007

Biologic may have synergistic effects with ImClone’s Erbitux and Genentech’s Avastin, firm tells “The Pink Sheet” DAILY.

More from Archive

More from Pink Sheet